EGFR and cancer: With an aim to identify the molecular mechanisms that control the biological process of disease progression in cancer, several studies have focused on the genetic backgrounds of cancer cells and its relative impact on prognosis and clinical outcome of cancer therapy, such as RRM1, EGFR and KRAS mutations2–6.